Um 18 Uhr geht's los: Jahresendrally - auf welche Aktien sollten Sie setzen? Jetzt kostenlos anmelden!
21.09.2021 16:46

exocad's ChairsideCAD Recognized as a 2021 Cellerant Best of Class Technology Award Winner

Folgen
Werbung

ChairsideCAD receives a Cellerant Technology Award for third consecutive year

DARMSTADT, Germany, Sept. 21, 2021 /PRNewswire/ -- exocad GmbH (exocad), an Align Technology, Inc. company and a leading dental CAD software provider, announced today that ChairsideCAD, its open-architecture CAD software for single-visit dentistry, received a 2021 Best of Class Technology Award from Cellerant Consulting Group. This is the third consecutive year that ChairsideCAD has been recognized for this award.

exocad announced that ChairsideCAD, its open-architecture CAD software for single-visit dentistry, received the 2021 Cellerant Best of Class Technology Award for a third consecutive year.

"We are honored to receive this prestigious industry award from dental industry leaders once again for our best-in-class software solution, and we're excited to share the power of ChairsideCAD with clinicians. This software can enhance the chairside design process, making it faster and more accurate," said Larry Bodony, president of exocad America, Inc. "The intuitive design workflow of ChairsideCAD, plus the freedom to use any open hardware, makes this a fantastic tool to streamline even the most challenging cases."

exocad stands as the software of choice for leading manufacturers of dental CAD/CAM systems because it is flexible, reliable and intuitive. Dental professionals consistently turn to exocad software to streamline their workflows for a broad range of indications. Based on exocad's renowned lab software DentalCAD, ChairsideCAD is the first complete open-architecture CAD software platform for single-visit dentistry. The software includes a step-by-step guide through the design process, simple integrations with a broad spectrum of devices and the ability to seamlessly share information between clinicians and labs.

Since the inaugural presentation in 2009, the Cellerant Best of Class Technology Awards have grown to occupy a unique space in dentistry by creating awareness in the community of manufacturers who are driving the discussion in how practices operate now and in the future. The 2021 Cellerant Best of Class Technology Award was decided on by a panel of prominent technology leaders in dentistry.

Additional information is available at:
www.exocad.com/chairsidecad  
www.cellerantconsulting.com/best-of-class-2021

About exocad GmbH

exocad GmbH, an Align Technology, Inc. company, is a leading dental CAD software provider. exocad vigorously pushes the boundaries of digital dentistry, providing flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices worldwide. More than 45,000 valued customers plan implants and create functional and refined restorations with exocad's DentalCAD,ChairsideCAD and exoplan software. For more information and a list of exocad reseller partners, please visit exocad.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exocads-chairsidecad-recognized-as-a-2021-cellerant-best-of-class-technology-award-winner-301381675.html

SOURCE exocad GmbH

Um 18 Uhr live: Jahresendrally - auf welche Aktien sollten Sie setzen?

Trotz eines vergleichsweise schwachen Marktes rechnen Experten mit einer intensiven Jahresendrally. Die Frage aller Fragen ist nun: Wer sind die Favoriten für 2022? Im Onine-Seminar heute ab 18 Uhr geben Ihnen Jürgen Schmitt und Mick Knauff einen exklusiven Ausblick.
Jetzt noch kostenlos anmelden!
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Wall Street freundlich -- DAX im Plus -- Software AG senkt Ausblick für Digital -- Delivery Hero steigt bei Gorillas ein -- GameStop, J&J, Apple, Munich Re, TeamViewer im Fokus

Amazon springt auf 3D-Audio-Zug auf. RWE will in Großbritannien bis 2030 rund 15 Milliarden Pfund investieren. E.ON nimmt Neukundengeschäft mit Gas wieder auf. Procter & Gamble veranlasst wegen steigender Kosten höhere Preise. Travelers übertrifft Erwartungen im dritten Quartal. Roche-Partner Atea kann mit Corona-Pille Ziele nicht erreichen. JENOPTIK übernimmt Berliner Glas Medical und Swissoptic.

Umfrage

Wo steht der DAX zum Jahresende?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln